Alb expressions are recommended to be a reliable prognostic factor in patients with cancer.[2] AFR, a ratio of Alb-to-Fib, combines these 2 biomarkers and amplifies the sensitivity for evaluating inflammation and nutrition status. The gene discussed is ALB; the disease is cancer.